fda warning bpc 157 safety human data From BPC-157 to TB-500 to AOD-9604—the world of injectable peptides is wild right now. And with the meeting to consider the deregulation of seven synthetic peptides in 2026, things very well FDA issued 25 warning letters
Description
HUBERMAN: And one of the more common ones is nausea
Because each vial contains a precise 0.9% benzyl alcohol preservative (9 mg/mL, the USP standard), it can be accessed repeatedly for as much as 28 days post-puncture when refrigerated and handled aseptically

Kraus D et al

Following this study, the efficacy of ixekizumab on the scalp was also evaluated in a randomized phase III clinical trial comparing ixekizumab 80 mg at 2-week dosing intervals, 4-week dosing intervals, and 4- to 2-week interval dose adjustment groups

per ampoule